XML 25 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Impact of adoption
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock Issued
Common Stock Issued
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-in Capital
Additional Paid-in Capital
Impact of adoption
 [2]
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock
Treasury Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Impact of adoption
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Non-Controlling Interest
Non-Controlling Interest
Impact of adoption
 [1]
Non-Controlling Interest
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning Balances (in shares) at Dec. 31, 2018       47,557                            
Beginning balance at Dec. 31, 2018 $ 1,795,924     $ 475   $ 593,262     $ (117,291)   $ (172,342)   $ 1,481,593     $ 10,227    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Stock issued under share-based compensation plans (in shares)       192                            
Stock issued under share-based compensation plans 4,941     $ 2   4,939                        
Share repurchases for tax withholdings (10,352)         (10,352)                        
Stock-based compensation expense 45,811         45,811                        
Change in value of redeemable non-controlling interest (57,315)         41,400             (98,715)          
Foreign currency translation adjustments 1,784               1,842             (58)    
Net income (loss) 155,729                       156,323     (594)    
Ending Balance (in shares) at Dec. 31, 2019       47,749 47,749                          
Ending balance at Dec. 31, 2019 $ 1,936,522 $ (8,777) [1] $ 1,927,745 $ 477 $ 477 675,060   $ 675,060 (115,449) $ (115,449) (172,342) $ (172,342) 1,539,201 $ (8,587) [1] $ 1,530,614 9,575 $ (190) $ 9,385
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Accounting Standards Update [Extensible List] Accounting Standards Update 2016-13                                  
Stock issued under share-based compensation plans (in shares)       290                            
Stock issued under share-based compensation plans $ 9,273     $ 2   9,271                        
Fair value of stock issued through private placement, net of issuance costs of $968 (in shares)       577                            
Fair value of stock issued through private placement, net of issuance costs of $968 92,976     $ 6   92,970                        
Share repurchases for tax withholdings (9,519)         (9,519)                        
Equity component of the Convertible Notes, net of allocated issuance costs of $570 and taxes of $13,623 41,066         41,066                        
Stock-based compensation expense 63,863         63,863                        
Change in value of redeemable non-controlling interest 40,312                       40,312          
Foreign currency translation adjustments 27,864               27,041             823    
Transfer of cumulative translation adjustment on the sale of subsidiary 5,473               5,473                  
Net income (loss) (281,136)                       (283,950)     2,814    
Ending Balance (in shares) at Dec. 31, 2020       48,616 48,616                          
Ending balance at Dec. 31, 2020 $ 1,917,917 $ (40,006) [2] $ 1,877,911 $ 485 $ 485 872,711 $ (41,982) $ 830,729 (82,935) $ (82,935) (172,342) $ (172,342) 1,286,976 $ 1,976 [2] $ 1,288,952 13,022   $ 13,022
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Accounting Standards Update [Extensible List] Accounting Standards Update 2020-06                                  
Stock issued under share-based compensation plans (in shares) 432     639                            
Stock issued under share-based compensation plans $ 44,197     $ 7   44,190                        
Share repurchases for tax withholdings (23,457)         (23,457)                        
Stock-based compensation expense 74,758         74,758                        
Acquisition of non-controlling interest, net of $538 in acquisition costs (Note 4) (97,530)         (82,169)     (2,284)             (13,077)    
Unrealized loss on available-for-sale debt securities (6,123)               (6,123)                  
Change in value of redeemable non-controlling interest (135,156)                       (135,156)          
Foreign currency translation adjustments (31,494)               (31,175)             (319)    
Net income (loss) 135,667                       135,293     374    
Ending Balance (in shares) at Dec. 31, 2021       49,255                            
Ending balance at Dec. 31, 2021 $ 1,838,773     $ 492   $ 844,051     $ (122,517)   $ (172,342)   $ 1,289,089     $ 0    
[1] Reflects the impact of the Company’s modified retrospective adoption of ASU 2016-13
[2] Reflects the impact of the Company’s modified retrospective adoption of ASU 2020-06 (See Note 1, Basis of Presentation and Summary of Significant Accounting Policies)